APA (7th ed.) Citation

EM, K., CD, M., J, L., KV, F., CJ, F., JA, A., . . . SK, G. (2023). Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 76(11), 2010. https://doi.org/10.1093/cid/ciad107

Chicago Style (17th ed.) Citation

EM, Kileel, et al. "Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE)." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 76, no. 11 (2023): 2010. https://doi.org/10.1093/cid/ciad107.

MLA (9th ed.) Citation

EM, Kileel, et al. "Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE)." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 76, no. 11, 2023, p. 2010, https://doi.org/10.1093/cid/ciad107.